6 months ended

31 August

2022

Interim

Results

Interim results | 6 months ended 31 August 2022

Disclaimer

The statements contained here in may contain certain forward-looking statements relating to the Group that are based on the beliefs of the Group's management as well as assumptions made by and information currently available to the Group's management. These forward-looking statements are, by their nature, subject to significant risks and uncertainties. These forward-looking statements, include without limitation, statements relating to the Group's business prospects, future developments, trends and conditions in the industry and geographical markets in which the Group operates, its strategies, plans, objectives and goals, its ability to control costs, statements relating to operations, margins, overall market trends, risk management and exchange rates. Forward-looking statements are provided to allow potential investors the opportunity to understand management's beliefs and opinions in respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment.

Although forward-looking statements contained in this presentation are based upon what management of the Company believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements apply only as of the date on which they are made, and Adcorp undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change. The reader is cautioned not to place undue reliance on forward-looking statements.

Interim results | 6 months ended 31 August 2022

2

Overview

Dr John Wentzel

Chief Executive Officer

Interim results | 6 months ended 31 August 2022

3

How did we do?

Revenue

Gross profit

PBT on continuing

up

up

operations up

Execution of growth

Capital effectively

Interim dividend of

strategy

deployed

12,2c per share

Interim results | 6 months ended 31 August 2022

4

What did we focus on in H1?

Execution of the growth strategy

Execution of the capital allocation framework

Lifted revenue 3.2%

Returned cash to shareholders via a dividend

Lifted gross profit 6.3%

Invested in organic growth

Customer satisfaction up

Invested in an acquisition

Cash management strong

Executed share buybacks

Interim results | 6 months ended 31 August 2022

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Adcorp Holdings Limited published this content on 31 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 November 2022 08:05:04 UTC.